Showing 1 - 7 results of 7 for search 'E Katodritou', query time: 0.03s Refine Results
  1. 1
    Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study

    Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study by E. Terpos, A. Symeonidis, S. Delimpasi, E. Zamagni, E. Katodritou, E. Rivolti, M. Kyrtsonis, D. Fotiou, N. Kanellias, M. Migkou, M. Roussou, M. Gavriatopoulou, E. Hatjiharissi, M. Cavo, M. Dimopoulos

    Published 2020-10-01
    Get full text
    Article
  2. 2
    P22: A NON-INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL-WORLD SETTINGS IN GREECE; INTERIM RESULTS OF THE ‘OL-ORAL’ STUDY

    P22: A NON-INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL-WORLD SETTINGS IN GREECE; INTERIM RESULTS... by E Katodritou, MC Kyrtsonis, S Delimpasi, E Spanoudakis, G Vassilopoulos, P Zikos, N Viniou, G Kaiafa, M Papathanasiou, V Pappa, E Michalis, I Adamopoulos, K Kokoviadou, G Tsirakis, C Poziopoulos, E Terpos

    Published 2022-04-01
    Get full text
    Article
  3. 3
    P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY

    P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY by E Terpos, I Ntanasis-Stathopoulos, E Kastritis, E Hatjiharissi, E Katodritou, E Eleutherakis-Papaiakovou, E Verrou, M Gavriatopoulou, A Leonidakis, S Delimpasi, P Malandrakis, M-C Kyrtsonis, M Papaioannou, A Symeonidis, MA Dimopoulos

    Published 2022-04-01
    Get full text
    Article
  4. 4
    P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL-WORLD DATA ANALYSIS FROM THE GREEK MYELOMA STUDY GROUP

    P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL-WORLD DATA ANALYSIS FROM THE... by E. Katodritou, D. Dalampira, T. Triantafyllou, M. Gavriatopoulou, S. Delimpasi, A. Pouli, T. Papadopoulou, E. Verrou, A. Sevastoudi, K. Tsirou, L. Katsika, G. Douganiotis, N. Karampatzakis, T.-E. Metallinou, V. Palaska, M. Kotsopoulou, C. Lalayianni, M.-C. Kyrtsonis, E. Spanoudakis, D. Maltezas, A. Chatzivasili, M.-A. Dimopoulos, E. Terpos, E. Kastritis

    Published 2022-06-01
    Get full text
    Article
  5. 5
    P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS

    P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK... by T. Vassilakopoulos, A. Piperidou, Z. Mellios, E. Verigou, C. Kalpadakis, E. Katodritou, S. Papageorgiou, C. Chatzidimitriou, C. Giatra, T. Leonidopoulou, V. Xanthopoulos, S. Karakatsanis, G. Gainaru, E. Vrakidou, A. Koumarianou, E. Hatzimichael, E. Verrou, M. Tsirogianni, I. Drandakis, M. A. Lefaki, A. Liaskas, A. Kopsaftopoulou, P. Lampropoulou, N. Kanellias, P. Zikos, D. Liapi, G. Karianakis, D. Grentzelias, E. Papadaki, M. Siakantaris, P. Tsirigotis, F. Panitsas, E. Plata, M. Bakiri, I. Datseris, S. Chatziioannou, V. Prassopoulos, E. Skoura, M. Angelopoulou, A. Symeonidis, T. Karmiris, P. Rontogianni

    Published 2022-06-01
    Get full text
    Article
  6. 6
    P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

    P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES by T. Vassilakopoulos, B. Ferhanoglu, N. A. Horowitz, J. Apostolidis, Z. Mellios, L. Kaynar, M. Zektser, A. Symeonidis, A. Piperidou, C. Kalpadaki, O. M. Akay, S. C. Atalar, A. Sayyed, E. Katodritou, T. Leonidopoulou, S. Papageorgiou, T. Tadmor, O. Gutwein, S. Karakatsanis, C. Ganzel, G. Karianakis, G. Isenberg, G. Gainaru, E. Vrakidou, M. Palassopoulou, M. Ozgur, M. Siakantaris, S. Paydas, P. Tsirigotis, M. Tsirogianni, E. Hatzimichael, T. F. Tuglular, C. Chatzidimitriou, A. Liaskas, M. A. Lefaki, N. Kanellias, P. Zikos, A. Koumarianou, A. Gafter-Gvili, M. Angelopoulou, T. Karmiris, R. Gurion

    Published 2022-06-01
    Get full text
    Article
  7. 7
    P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

    P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP by Theodoros Vassilakopoulos, B Ferhanoglu, Na Horowitz, J Apostolidis, Z Mellios, Alexia Piperidou, L Kaynar, M Zektser, A Giotasmater, Dei Hospital, Msida Malta, A Symeonidis, C Kalpadakis, A Agathocleous, Om Akay, A Sayyed, Sc Atalar, E Katodritou, T Leonidopoulou, Sg Papageorgiou, T. Tadmor, O Gutwein, S Karakatsanis, C Ganzel, G. Karianakis, G. Y. Isenberg, G Gainaru, E. Vrakidou, M Palassopoulou, M Ozgur, Marina Siakantaris, S Paydas, P Tsirigotis, M Tsirogianni, E Hatzimichael, Tf Tugular, Jv Assimakopoulos, L Ligdi, A Liaskas, Maria Aikaterini Lefaki, P Labropoulou, A Kopsaftopoulou, E Verrou, M Kanellias, P Zikos, A Koumarianou, A Gafter-Gvili, M Bouzani, Mk Angelopoulou, T Karmiris, R Gurion

    Published 2023-08-01
    Get full text
    Article

Search Tools: